IgA 血管炎 (埃诺克-申林紫外线):关于治疗的最新情况
Santos Castañeda1,2, Patricia Quiroga-Colina1, Paz Floranes1
1Rheumatology Division, H. Universitario La Princesa, IIS-Princesa, 28006 Madrid, Spain.
IgA血管炎 (IgAV) 是一种常见的儿童血管炎,但在成年人中更严重. 葡萄皮质皮质类药物是第一线药物,像Rituximab这样的生物药物显示出缓解和减少副作用的希望.
科学领域:
- 类风湿病学 类风湿病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 儿科 儿科 儿科
背景情况:
- IgA血管炎 (IgAV),前身是亨诺赫-施恩莱因紫外线,是儿童中最常见的全身血管炎.
- 成年IgAV较少发生,但与更严重的疾病有关,包括IgAV炎的发病率更高,进展到末期病.
研究的目的:
- 审查IgA血管炎的病理生理学,临床特征,诊断和新兴疗法.
- 突出IgAV治疗的最新进展,重点关注生物药物和新的治疗策略.
主要方法:
- 关于PubMed索引文章的叙事文献评论.
- 对IgAV当前和研究中的治疗方法的分析,包括常规药物,免疫调节剂和生物制剂.
主要成果:
- 葡萄糖皮质类药物是严重IgAV的主要治疗方法,特别是在成年人中.
- 免疫调节剂 (环素A,塔克罗利木斯,美酸莫菲提尔) 显示出作为类固醇节省选择的希望.
- 利图西马布在减少IgAV复发,减少类固醇依赖和实现长期缓解方面表现出有效性.
结论:
- 葡萄糖皮质类药物仍然是严重IgAV的第一线治疗.
- 免疫调节疗法和rituximab为IgAV管理提供了有价值的治疗选择.
- 对于新型疗法,如TRF-budesonide和补充途径抑制剂,需要进一步的研究.
更多相关视频
10:09Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound
Published on: August 4, 2022
05:44Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
Published on: May 24, 2024
相关概念视频
Rheumatic Heart Disease III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antihypertensive Drugs: Vasodilators
Myocarditis III: Medical Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
